Quest Diagnostics Inc
NYSE:DGX
Intrinsic Value
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. [ Read More ]
The intrinsic value of one DGX stock under the Base Case scenario is 140.36 USD. Compared to the current market price of 125.91 USD, Quest Diagnostics Inc is Undervalued by 10%.
Valuation Backtest
Quest Diagnostics Inc
Run backtest to discover the historical profit from buying and selling DGX stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Quest Diagnostics Inc
Current Assets | 2.4B |
Cash & Short-Term Investments | 686m |
Receivables | 1.2B |
Other Current Assets | 476m |
Non-Current Assets | 11.7B |
Long-Term Investments | 135m |
PP&E | 2.4B |
Intangibles | 8.9B |
Other Non-Current Assets | 198m |
Current Liabilities | 1.8B |
Accounts Payable | 1.4B |
Accrued Liabilities | 153m |
Other Current Liabilities | 303m |
Non-Current Liabilities | 5.9B |
Long-Term Debt | 4.4B |
Other Non-Current Liabilities | 1.5B |
Earnings Waterfall
Quest Diagnostics Inc
Revenue
|
9.3B
USD
|
Cost of Revenue
|
-6.2B
USD
|
Gross Profit
|
3.1B
USD
|
Operating Expenses
|
-1.8B
USD
|
Operating Income
|
1.3B
USD
|
Other Expenses
|
-466m
USD
|
Net Income
|
850m
USD
|
Free Cash Flow Analysis
Quest Diagnostics Inc
What is Free Cash Flow?
DGX Profitability Score
Profitability Due Diligence
Quest Diagnostics Inc's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Score
Quest Diagnostics Inc's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
DGX Solvency Score
Solvency Due Diligence
Quest Diagnostics Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Score
Quest Diagnostics Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DGX Price Targets Summary
Quest Diagnostics Inc
According to Wall Street analysts, the average 1-year price target for DGX is 145.13 USD with a low forecast of 126.25 USD and a high forecast of 162.75 USD.
Ownership
DGX Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
DGX Price
Quest Diagnostics Inc
Average Annual Return | 19.35% |
Standard Deviation of Annual Returns | 17.44% |
Max Drawdown | -37% |
Market Capitalization | 14B USD |
Shares Outstanding | 110 710 000 |
Percentage of Shares Shorted | 2.62% |
DGX News
Last Important Events
Quest Diagnostics Inc
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Quest Diagnostics Inc
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. The company is headquartered in Secaucus, New Jersey and currently employs 40,000 full-time employees. The firm operates through DIS segment, which provides diagnostic information services to a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers, accountable care organizations (ACOs) and direct contract entities (DCEs). The company is also engaged in two business operations, Diagnostic Information Services, which develops and delivers diagnostic information services that provides insights to a range of customers, and the Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company’s services primarily are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne and Quanum.
Contact
IPO
Employees
Officers
The intrinsic value of one DGX stock under the Base Case scenario is 140.36 USD.
Compared to the current market price of 125.91 USD, Quest Diagnostics Inc is Undervalued by 10%.